GAIN THERAPEUTICS INC's ticker is GANX and the CUSIP is 36269B105. A total of 20 filers reported holding GAIN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $689,000 | +665.6% | 210,000 | +947.6% | 0.00% | – |
| Q2 2023 | $90,000 | -52.1% | 20,046 | -48.6% | 0.00% | – |
| Q1 2023 | $188,000 | +54.1% | 39,000 | 0.0% | 0.00% | – |
| Q4 2022 | $122,000 | -3.9% | 39,000 | -0.2% | 0.00% | – |
| Q3 2022 | $127,000 | -9.3% | 39,086 | +0.2% | 0.00% | – |
| Q2 2022 | $140,000 | -31.7% | 39,000 | -22.0% | 0.00% | – |
| Q1 2022 | $205,000 | +259.6% | 50,000 | +373.5% | 0.00% | – |
| Q4 2021 | $57,000 | – | 10,560 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 150,000 | $489,000 | 0.63% |
| CM Management, LLC | 125,000 | $408,000 | 0.46% |
| Greenlight Capital | 546,560 | $1,781,000 | 0.13% |
| Wealth Alliance Advisory Group, LLC | 25,000 | $82,000 | 0.04% |
| Cannell Capital | 12,371 | $40,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 58,100 | $189,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 40,000 | $130,000 | 0.00% |
| HOEY INVESTMENTS, INC | 500 | $2,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 87,967 | $286,000 | 0.00% |